Glycomet GP 0.5mg/500mg Tablet PR 15s

Introduction to Glycomet GP 0.5mg/500mg Tablet PR 15s

Glycomet GP 0.5mg/500mg Tablet PR 15s is a prescription medication in tablet form primarily used for managing type 2 diabetes. This medication combines two active ingredients, Glimepiride and Metformin, to help control blood sugar levels effectively.

Composition of Glycomet GP 0.5mg/500mg Tablet PR 15s

Glycomet GP 0.5mg/500mg Tablet PR 15s contains Glimepiride (0.5mg) and Metformin (500mg). Glimepiride stimulates the pancreas to release insulin, while Metformin reduces glucose production in the liver and improves insulin sensitivity.

Uses of Glycomet GP 0.5mg/500mg Tablet PR 15s

• Management of type 2 diabetes
• Helps reduce the risk of diabetes-related complications such as heart disease, kidney problems, and nerve damage

Side effects of Glycomet GP 0.5mg/500mg Tablet PR 15s

• Common: Diarrhea, nausea, stomach discomfort
• Serious: Lactic acidosis, hypoglycemia, allergic reactions, hemolytic anemia in G6PD deficiency

Precautions of Glycomet GP 0.5mg/500mg Tablet PR 15s

Patients with severe renal impairment or liver disease should use Metformin with caution due to the risk of lactic acidosis. Glimepiride should be used cautiously in patients with G6PD deficiency. Regular monitoring of blood sugar levels is essential.

How to Take Glycomet GP 0.5mg/500mg Tablet PR 15s

Glycomet GP 0.5mg/500mg Tablet PR 15s should be taken orally with meals as prescribed by your healthcare provider. Dosage adjustments may be necessary based on blood sugar control and patient tolerance.

Conclusion of Glycomet GP 0.5mg/500mg Tablet PR 15s

Glycomet GP 0.5mg/500mg Tablet PR 15s, manufactured by USV Ltd, is a combination of Glimepiride and Metformin used in the therapeutic class of antidiabetic medications. It effectively manages type 2 diabetes and reduces the risk of associated complications. Always consult your healthcare provider for personalized advice and dosage instructions.